Progenics Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
65,860.00
119,302.00
74,103.00
140,609.00
90,642.00
137,686
Total Accounts Receivable
2,879.00
109.00
3,543.00
4,864.00
3,972.00
3,803
Other Current Assets
1,943.00
2,515.00
5,639.00
2,628.00
2,256.00
2,640
Total Current Assets
70,682.00
121,926.00
83,285.00
148,101.00
96,870.00
144,129
Net Property, Plant & Equipment
2,413.00
2,552.00
2,407.00
4,760.00
4,122.00
3,944
Total Investments and Advances
2,208.00
-
1,692.00
2,000.00
-
1,534
Long-Term Note Receivable
157.00
-
-
-
2,109.00
-
Intangible Assets
39,081.00
36,402.00
43,867.00
43,655.00
43,443.00
19,740
Other Assets
-
157.00
-
470.00
1,522.00
150
Total Assets
114,541.00
161,037.00
131,251.00
198,986.00
148,066.00
169,497
ST Debt & Current Portion LT Debt
-
-
-
-
2,445.00
Accounts Payable
793.00
1,040.00
452.00
567.00
3,359.00
Other Current Liabilities
5,834.00
5,645.00
9,277.00
15,790.00
9,555.00
Total Current Liabilities
6,627.00
6,685.00
9,729.00
16,357.00
15,359.00
Long-Term Debt
-
-
-
49,453.00
47,242.00
Provision for Risks & Charges
15,700.00
-
18,800.00
14,200.00
16,800.00
Deferred Taxes
12,321.00
11,332.00
11,199.00
13,010.00
1,575.00
Other Liabilities
914.00
18,111.00
862.00
1,204.00
1,528.00
Total Liabilities
35,562.00
36,128.00
40,590.00
94,224.00
82,504.00
Common Equity (Total)
78,979.00
124,909.00
90,456.00
104,762.00
65,562.00
Total Shareholders' Equity
78,979.00
124,909.00
90,456.00
104,762.00
65,562.00
Total Equity
78,979.00
124,909.00
90,661.00
104,762.00
65,562.00
Liabilities & Shareholders' Equity
114,541.00
161,037.00
131,251.00
198,986.00
148,066.00
Accumulated Minority Interest
-
-
205.00
-
-
About Progenics Pharmaceuticals
View Profile
